Secretory leukocyte protease inhibitor:
✍
Nancy R Shine; Susan C Wang; Krystyna Konopka; Elizabeth A Burks; Nejat Düzgüneş
📂
Article
📅
2002
🏛
Elsevier Science
🌐
English
⚖ 150 KB
The ability of the salivary protein, secretory leukocyte protease inhibitor (SLPI), to inhibit human immunodeficiency virus-1 (HIV-1) infection in vitro has been reported previously and has led to the suggestion that SLPI may be partially responsible for the low oral transmission rate of HIV-1. Howe